SVB Wealth LLC Has $2.48 Million Position in CME Group Inc. $CME

Key Points

• SVB Wealth LLC increased its stake in CME Group Inc. by 111.7% in the first quarter, owning 9,340 shares valued at approximately $2,478,000.
• CME Group recently reported quarterly earnings of $2.96 per share, exceeding consensus estimates, with a revenue of $1.69 billion and a net margin of 58.48%.
• The company declared a quarterly dividend of $1.25 per share, translating to an annualized dividend of $5.00 and a yield of 1.9%.

SVB Wealth LLC grew its position in CME Group Inc. (NASDAQ:CME - Free Report) by 111.7% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 9,340 shares of the financial services provider's stock after acquiring an additional 4,929 shares during the quarter. SVB Wealth LLC's holdings in CME Group were worth $2,478,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also made changes to their positions in the company. Wayfinding Financial LLC bought a new stake in shares of CME Group in the 1st quarter valued at approximately $25,000. Cornerstone Planning Group LLC increased its holdings in shares of CME Group by 122.2% in the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock valued at $26,000 after acquiring an additional 55 shares during the last quarter. Golden State Wealth Management LLC increased its holdings in shares of CME Group by 612.5% in the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock valued at $30,000 after acquiring an additional 98 shares during the last quarter. Alpine Bank Wealth Management bought a new stake in shares of CME Group in the 1st quarter valued at approximately $32,000. Finally, Financial Gravity Asset Management Inc. bought a new stake in shares of CME Group in the 1st quarter valued at approximately $32,000. 87.75% of the stock is currently owned by institutional investors.

Insider Activity

In other CME Group news, Director William R. Shepard bought 256 shares of the firm's stock in a transaction that occurred on Wednesday, June 25th. The stock was purchased at an average price of $270.53 per share, for a total transaction of $69,255.68. Following the purchase, the director directly owned 258,196 shares in the company, valued at $69,849,763.88. This trade represents a 0.10% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Charles P. Carey sold 500 shares of CME Group stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $265.35, for a total value of $132,675.00. Following the sale, the director directly owned 4,900 shares in the company, valued at $1,300,215. The trade was a 9.26% decrease in their position. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the company. Erste Group Bank downgraded CME Group from a "strong-buy" rating to a "hold" rating in a report on Saturday, May 24th. Piper Sandler upped their price objective on CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a report on Tuesday, July 15th. Barclays set a $298.00 price objective on CME Group and gave the company an "equal weight" rating in a report on Thursday, July 24th. Oppenheimer upped their price objective on CME Group from $300.00 to $303.00 and gave the company an "outperform" rating in a report on Thursday, July 24th. Finally, Citigroup upped their price objective on CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a report on Thursday, July 3rd. Four research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $261.93.

CME Group Stock Down 0.5%

Shares of NASDAQ CME traded down $1.49 during mid-day trading on Wednesday, reaching $270.12. 1,397,216 shares of the company traded hands, compared to its average volume of 2,322,688. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a market cap of $97.35 billion, a PE ratio of 26.15, a price-to-earnings-growth ratio of 4.91 and a beta of 0.44. The company's fifty day moving average is $275.93 and its two-hundred day moving average is $268.87. CME Group Inc. has a fifty-two week low of $207.75 and a fifty-two week high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, beating analysts' consensus estimates of $2.91 by $0.05. The business had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The firm's revenue for the quarter was up 10.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.56 EPS. On average, analysts expect that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th will be issued a dividend of $1.25 per share. The ex-dividend date of this dividend is Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.9%. CME Group's dividend payout ratio is currently 48.40%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.